Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans

NCT04313634 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dasatinib
DRUG: Quercetin
DRUG: Fisetin

Sponsor

Sundeep Khosla, M.D.